Back to the main directory
Company Analysis / Equity
- Analyst Pin-board: Earnings results of the listed companies in 2019 by Viet Dragon Securities
- Result Previews: OGDC 1HFY20 & NBP CY19 , (AKD Daily, Feb 26, 2020) by AKD Securities Limited
- MILIBOO - CA T3 2019/20: 8,5 m€, +32,6%, nouveau record - Opinion Achat - Objectif: 4,17€ - Potentiel:+106,4% by GreenSome Finance
- VinaCapital Vietnam Opportunity Fund by Winterflood Securities
- DANONE NEUTRAL | EUR76 Revision to 2020 guidance by Bryan Garnier
- IPSEN NEUTRAL | EUR81 How much do disappointing US Cabometyx sales speak for Ipsen too? by Bryan Garnier
- EDENRED BUY - Top Picks | EUR54 FY results: very good and resolutely confident in growth prospects by Bryan Garnier
- ReNeuron Group - Stable 12-month vision by Edison Investment Research
- Daily Market briefing - West African Regional Stock Exchange by Hudson & Cie
- Diversifizierung trotzt schwacher Konjunktur im Rumpfgeschäftsjahr 2019 – Margendruck by EQUITS GmbH
- MOSL: FEDERAL BANK (Buy)-Asset quality turning better; RoA expansion to continue by Motilal Oswal
- Analyst Pin-board: Summary of LTG's performance in 2019 by Viet Dragon Securities
- 6PM Call: Short-term balance by Viet Dragon Securities
- Play: (i) 4Q19 results released (decent, yet unsurprising); (ii) FY20 management guidance (in line with expectations, perhaps with slightly positive flavour); (iii) CFO steps down by BOS Brokerage
- Asbis: 4Q19 results released – strong profits, above the FY19 upgraded management guidance, positive OCF by BOS Brokerage
- DM BOŚ: Daily research report – date 27.02.2020 by BOS Brokerage
- ZALANDO: 2020 guidance already priced in by the CS | BUY | EUR47(+7%) by Bryan Garnier
- GROUPE SEB: 2019 results matched forecasts but turbulence is not over | BUY | Under Review by Bryan Garnier
- SUEZ: Feedback from conference call | SELL | EUR11,5(-25%) by Bryan Garnier
- GRANDVISION: GrandVision keeps to its 2023 roadmap | BUY | EUR28(+1%) by Bryan Garnier
- CARREFOUR: First margin reversal in France since 2014 | BUY - Top Picks | EUR21(+32%) by Bryan Garnier
- VALNEVA: An excellent 2019 year for existing vaccines | BUY | EUR6(+87%) by Bryan Garnier
- BUREAU VERITAS: Results that reflect the soundness of the group's strategy...but major uncertainties for 2020 | BUY | EUR26(+8%) by Bryan Garnier
- ADYEN: Results broadly in-line overall but the EBITDA margin is slightly disappointing | SELL | Under Review vs. EUR490 by Bryan Garnier
- HERMÈS INTL.: Short-term negative impact likely due to Covid-19, but mid-term prospects unchanged | NEUTRAL | EUR570(-14%) by Bryan Garnier
- MLCF_1HFY20 LPS clocked in at PKR1.61 , (AKD, Off the Analyst's Desk, Feb 26, 2020) by AKD Securities Limited
- DM BOŚ: Daily research report – date 26.02.2020 by BOS Brokerage
- Kenya Power & Lighting Company Plc (NSE: KPLC) FY19 Earnings Note by Genghis Capital
- ASM INTERNATIONAL BUY - Top Picks | EUR130 ASMI delivers solid guidance for H1 2020 by Bryan Garnier
- COFACE BUY | EUR12,5 The investment case remains appealing by Bryan Garnier
- SUEZ SELL | EUR11,5 First take: Good revenue growth but EBIT growth a bit too shy by Bryan Garnier
- GRANDVISION BUY | EUR28 Digitalisation continued to weigh on FY19 margins, MT outlook confirmed for FY20 by Bryan Garnier
- BlackRock Latin American Inv. Trust - Celebrating its 30-year anniversary by Edison Investment Research
- Guidance 2019 erreicht - COVID-19 verschiebt Zyklustief by EQUITS GmbH
- Gerresheimer 2020e: Mehr Wachstum - weniger Profit und Einmaleffekte by EQUITS GmbH
- MOSL: CHOLAMANDALAM INV. & FINANCE (Buy)-Growth slowing down; M&HCV stress to last 8-9 months by Motilal Oswal
- MOSL: Morning India (27/February/20): 1. Federal Bank (Asset quality turning better; RoA expansion to continue); 2. Hindustan Unilever; 3. Cholamandalam Inv. & Fin.; 4. Mahindra CIE by Motilal Oswal
- LUCK: Near term headwinds clouding outlook , (AKD Daily, Feb 27, 2020) by AKD Securities Limited
- LiveChat: 4Q19 results released – (i) a tad weaker than expected profits, (ii) negative net add for December by BOS Brokerage
- Pekao: Pekao results’ review – meeting expectations, stronger than other income, but coupled with rising provisions by BOS Brokerage
- Norcros - Overseas challenges reduce estimates by Edison Investment Research
- ASM INTERNATIONAL: Remains our favourite call | BUY - Top Picks | EUR135 vs. EUR130 (+14%) by Bryan Garnier
- DANONE: COVID-19 aggravating the sales growth issue | NEUTRAL | EUR72 vs. EUR76 (+6%) by Bryan Garnier
- AB INBEV: Corona virus is more than halving Chinese revenues | BUY | EUR100(+61%) by Bryan Garnier
- EIFFAGE: Solid results, positive momentum, attractive outlook | BUY | EUR110(+3%) by Bryan Garnier
- ABIVAX: ABX196, the « smaller kid », also progresses | CORPORATE | EUR37.5(+122%) by Bryan Garnier
- BAYER: Q4 2019 results slightly better – 2020 guidance below expectations | NEUTRAL | EUR67(-5%) by Bryan Garnier
- MELIA HOTELS: A certain resilience despite many headwinds; Cautious stance mains on 2020 | BUY | EUR11.4(+70%) by Bryan Garnier
- EKINOPS: FY 2019 results confirm solid growth potential | BUY | EUR6.9(+27%) by Bryan Garnier
- FNAC DARTY: 4% dividend yield might not be enough to recreate momentum | NEUTRAL | EUR61(+42%) by Bryan Garnier